Hunter Taubman Fischer & Li LLC has advised Elite Express Holding Inc. on the offering, and Sullivan & Worcester has advised the underwriters. Elite Express Holding...
Elite Express Holding Closes $15.2 Million Initial Public Offering
BiomX’s $12 Million Financing
Haynes and Boone served as legal counsel to BiomX, while Sullivan & Worcester served as legal counsel to Laidlaw on the transaction. BiomX Inc (NYSE American:...
Oxbridge Re Holdings Limited’s $3 Million Shares Offering and Private Placement
Sullivan & Worcester was placement agent’s counsel for Maxim Group LLC in the offering. Oxbridge Re Holdings Limited (Nasdaq: OXBR) announced its $3 million registered direct...
Plus Therapeutics’ $15 Million Private Placement
Sullivan & Worcester and Hogan Lovells US advised Plus Therapeutics, while Sichenzia Ross Ference Carmel represented D. Boral Capital on the offering. Plus Therapeutics, Inc. (Nasdaq:...
Digital Ally’s $15 Million Common Stock Offering
Sullivan & Worcester acted as counsel to Digital Ally, while Kaufman & Canoles acted as counsel to Aegis Capital Corp. Digital Ally, Inc. (Nasdaq: DGLY) announced...
Elutia’s $15 Million Registered Direct Offering
Sullivan & Worcester represented Lake Street Capital Markets on the offering. Elutia Inc. (Nasdaq: ELUT) has entered into a definitive agreement with investors for the purchase...
Evaxion’s $10.8 Million Public Offering
Sullivan & Worcester advised Lake Street Capital Markets and Jones, placement agents for the offering. Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing...
Pharma Two B’s Merger With Hepion Pharmaceuticals
Sheppard, Mullin, Richter & Hampton is acting as U.S. legal advisor to Hepion and Lipa Meir & Co. is acting as Israeli legal advisor to Hepion....
BranchOut Food’s $1.4 Million Follow-On Public Offering
Pachulski Stang Ziehl & Jones served as counsel to BranchOut, while Sullivan & Worcester served as counsel to the underwriters. BranchOut Food announced the closing of...
Achieve Life Sciences’ Direct Offering and Concurrent Private Placement
Fenwick & West represented Achieve Life Sciences, while Sullivan & Worcester represented Lake Street Capital Markets, LLC and JonesTrading Institutional Services LLC on the transaction. Achieve...
Achieve Life Science’s $124.2 Million Registered Direct Offering and Concurrent Private Placement
Fenwick & West represented Achieve Life Science, while Sullivan & Worcester represented Lake Street Capital Markets in the transaction. Achieve Life Sciences, Inc. (Nasdaq: ACHV), a...
Chromocell Therapeutics Corporation’s $6.6 Million Initial Public Offering
Sullivan & Worcester represented Chromocell Therapeutics Corporation, while Manatt, Phelps & Phillips represented A.G.P./ Alliance Global Partners in the transaction. Chromocell Therapeutics Corporation executed their $6.6...



































